Canaccord Genuity Maintains Buy on Core Scientific, Maintains $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Joseph Vafi has reiterated a Buy rating for Core Scientific (NASDAQ:CORZ) and maintained a price target of $16.
October 11, 2024 | 6:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity has reiterated its Buy rating for Core Scientific, maintaining a price target of $16, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and maintenance of a $16 price target by Canaccord Genuity suggests a positive outlook for Core Scientific, likely boosting investor confidence and potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100